Research detects the anti-inflammatory effect of MiS on cells and molecules

12 April 2021 - Research -
Share

ASAcampus is constantly at the forefront in developing new research. The latest is “Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing” che si which aimed to study the anti-inflammatory activity of MiS, the ASA device capable of combining the synchronised action of MLS® Laser Therapy with the pulse power of Hilterapia®, from the cellular and molecular point of view.

The in-vitro study was carried out on human dermal fibroblasts exposed firstly to a mix of inflammatory cytokines (IL‐1β and TNF‐α) which subsequently underwent treatment with MiS.

Three types of samples were analysed:

  • the first concerned human fibroblasts stimulated with IL‐1β and TNF‐α for 48 hours which subsequently underwent 3 laser treatments (once a day for 4 consecutive days);
  • the second envisaged a similar stimulation mix, but avoided exposure to the laser;
  • the third neither underwent stimulation, nor laser.

After analysing the results, the researchers noted that the main pathways signalling inflammation were increased (or activated) by the mix of cytokines, whilst treatment with MiS lowered the levels, restoring basal levels, in a statistically significant manner.  The same was noted when assessing the VEGF levels (the factor involved in neovascularisation of granular tissue).

The research also allowed analysing some of the most important cytoskeletal proteins which had modified their organisation after stimulation with cytokines, and returned to the basal distribution after treatment with MiS.

It can therefore be concluded that not only does the ASA device have an important anti-inflammatory effect, but it is also effective in controlling fibroblast activation induced by IL‐1β and TNF‐α, probably responsible for a detrimental effect on the inflammation’s evolution, which favours its persistence.
 

Testo a Destra
Immagine 30%/Testo 60%

“Effect of NIR Laser Therapy by MLS‐MiS Source on Fibroblast Activation by Inflammatory Cytokines in Relation to Wound Healing”
S. Genah, F. Cialdai, V. Ciccone, E. Sereni, L. Morbidelli, M. Monici
Biomedicines 9, 307, 2021

READ MORE

You might also be interested in ...

See all articles

ASA Research Division
Successful Cases - 26/03/2020
There is a close connection between the growth of ASA and the scientific production in the biomedical field. Since its inception, the company understood how important a role research would play in...
myelin thickness with MLS laser MiS
Research
L. Micheli, F. Cialdai, A. Pacini, J.J.V. Branca, L. Morbidelli, V. Ciccone, E. Lucarini, C. Ghelardini, M. Monici, L. Di Cesare Mannelli Nature Scientific Reports, 9:9297, 2019
MiS handpieces
Research
S. Genah, F. Cialdai, V. Ciccone, E. Sereni, L. Morbidelli, M. Monici Biomedicines 9, 307, 2021 The present study demonstrates that the proposed NIR laser therapy is effective in controlling...
ASA Partners Meeting 2024
News - 21/03/2024
Four days of full immersion in the world of ASA to focus on the new devices - M-Hi and HIRO – and to analyse the biological effects of Hilterapia®.
ASAlaser @ FIF Milano 2024
News - 19/03/2024
Not only top-of-the-line devices, including the new HIRO and M-Hi as well as Magneto Qs and M8, but also three workshops aimed at highlighting the strengths of its therapies.
ASA tema @ ArabHealth 2024
News - 15/02/2024
In order to provide maximum visibility and the best dissemination of the strengths of its Therapeutic Solutions, the company preceded its attendance at the fair (Dubai, 29th January – 1st February)...